After resveratrol treatment, nuclear labeling of p-STAT3, β-catenin and HES1 become rare and weakened, indicating the concurrent inhibition of the biological activities of STAT3, Notch and Wnt2 signaling by this multi-targeting compound and its correlation with the suppressed growth of ovarian cancer cells. Here, HES1 is linked to ovarian carcinoma.